跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
达珂 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Decitabine for Injection
Approved
化学药品
Decitabine for Injection
Janssen-Cilag International NV
🇨🇳 National Medical Products Administration
Approval Date
Feb 2, 2026
Approval ID
887fAX67NGi
Company
Janssen-Cilag International NV
Type
化学药品
Approval Details
Approval Id
887fAX67NGi
Approval Number
国药准字HJ20181217
Generic Name
注射用地西他滨
Generic Name En
Decitabine for Injection
Trade Name
达珂
Drug Type
化学药品
Dosage Form
注射剂
Strength
50mg
Reg Date
2026-02-02
Expired Date
2031-02-01
Company Name
Janssen-Cilag International NV
Company Detail Path
/organization/janssen-cilag-international-nv
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 2, 2026
Approval ID
887fAX67NGi
Type
化学药品
Back to NMPA Approvals